デフォルト表紙
市場調査レポート
商品コード
1564953

凝固/止血分析装置の世界市場

Coagulation / Hemostasis Analyzers


出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
凝固/止血分析装置の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

凝固/止血分析装置の世界市場は2030年までに50億米ドルに達する見込み

2023年に41億米ドルと推定される凝固/止血分析装置の世界市場は、分析期間2023-2030年にCAGR 3.0%で成長し、2030年には50億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである臨床検査分析装置は、CAGR 2.2%を記録し、分析期間終了時には38億米ドルに達すると予測されます。ポイントオブケア検査分析装置セグメントの成長率は、分析期間中CAGR 6.1%と推定されます。

米国市場は11億米ドル、中国はCAGR 5.3%で成長すると予測

米国の凝固/止血分析装置市場は2023年に11億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを5.3%として、2030年までに10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.5%と3.7%と予測されています。欧州では、ドイツがCAGR 1.2%で成長すると予測されています。

世界の凝固/止血分析装置市場- 主要動向と促進要因のまとめ

なぜ凝固/止血分析装置はヘルスケアに不可欠なのか?

凝固・止血分析装置は、現代のヘルスケアにおいて不可欠なツールです。これらの分析装置は体内の血液凝固機能を評価するために使用され、血液凝固に関連する疾患の診断、治療、管理に不可欠です。血液凝固障害は、過剰な出血や血栓症(過剰な凝固)を引き起こす可能性があり、いずれも生命を脅かす危険性があります。凝固分析装置は、プロトロンビン時間(PT)、活性化部分トロンボプラスチン時間(aPTT)、フィブリノゲン値、Dダイマーなどのさまざまな検査を実施し、ヘルスケア担当者が患者の血液凝固の程度を判断するのに役立ちます。これらの検査は、抗凝固療法を受けている患者の管理、血友病などの出血性疾患の評価、手術の準備などに不可欠です。外傷や脳卒中などの緊急事態では、迅速な凝固検査によって即座に治療方針を決定し、人命を救うことができます。健康全般における血液凝固の重要性を考えると、凝固分析装置は心臓病学、腫瘍学、外科分野だけでなく、一般臨床の診断においても中心的な役割を担っています。

凝固・止血分析装置はなぜ先進的なのか?

凝固・止血分析装置は、迅速かつ正確で信頼性の高い結果を得るための最先端技術を駆使した高度な装置です。これらの装置は、光学的、機械的、電気化学的手法など、さまざまな方法で凝固プロセスを測定します。例えば、光学式分析装置は、血液が凝固し始める際の試料の濁度(濁り)の変化を検出し、正確でリアルタイムのデータを提供します。機械システムは血液サンプルの動きや粘度の変化をモニターし、電気化学システムは血栓形成に伴う電気伝導度の変化を測定します。これらの技術が統合されているため、凝固検査は迅速に完了します。これは、迅速な診断が最優先されるクリティカルケアでは必要不可欠です。最新の凝固分析装置は自動化機能も備えており、複数の検体を同時に処理できるため、検査室の効率が向上します。また、少量の血液でさまざまな検査を実施できるため、ポイントオブケアだけでなく、ハイスループットの臨床検査室での使用にも理想的です。これらの分析装置には高度なアルゴリズムとデータ分析ツールが搭載されており、人為的ミスを排除し、標準化された結果を提供することで精度を高めています。さらに、検査情報システム(LIS)と連携していることが多く、ヘルスケアチーム全体でシームレスなデータ共有が可能です。このような技術の統合により、凝固分析装置はより迅速で信頼性が高いだけでなく、拡張性も向上し、病院、診療所、研究機関などからの需要の高まりにも対応できるようになりました。

凝固・止血分析装置は現代医療においてどのように進化しているのか?

凝固・止血分析装置は、個別化医療、外来診療、技術の進歩といった新たな需要によって変化するヘルスケアの状況に応じて急速に進化しています。大きな動向の1つは、凝固分析装置の小型化と携帯化であり、これによってPOCT(Point of Care Testing)が可能になった。この変化により、ヘルスケアプロバイダーは患者のベッドサイドや救急外来、さらには在宅医療の現場で、凝固検査結果をリアルタイムで直接提供できるようになりました。ポータブル凝固分析装置は、ワルファリンや直接経口抗凝固薬(DOAC)など、過剰出血や血栓形成などの合併症を避けるために頻繁なモニタリングが必要な抗凝固療法を長期間受けている患者にとって特に有益です。現場での検査や治療調整が可能になることで、患者の転帰が改善され、現代のヘルスケアにおいて重要な考慮事項である通院の必要性が減少します。さらに、デジタル技術と人工知能(AI)の統合により、凝固分析装置の機能が向上しています。凝固検査結果の解析にAIや機械学習アルゴリズムを使用するケースが増えており、患者の健康状態についてより深い洞察を提供し、凝固障害をより正確に予測できるようになっています。これらのシステムは、異常な結果にフラグを立てたり、過去のデータに基づいて潜在的な診断や治療法の調整を提案したりすることもでき、臨床医がより多くの情報に基づいた判断を下すのに役立ちます。さらに、最近の分析装置の多くはクラウド接続機能を備えており、ヘルスケアプロバイダーと検査室間の遠隔モニタリングやリアルタイムのデータ共有が可能になっています。これは、慢性患者や化学療法のような複雑な治療を受けている患者の管理に特に有用であり、凝固モニタリングが不可欠です。試薬の処方、センサー技術、自動化の進歩により、これらの分析装置はより正確で効率的なものとなり、サンプルの汚染や不正確な測定値の可能性を減らしています。

何が凝固/止血分析装置市場の成長を牽引しているのか?

凝固・止血分析装置市場の成長は、医療技術の進歩、患者のニーズ、ヘルスケアモデルの進化に直接関連するいくつかの要因によって牽引されています。主な要因の1つは、心血管疾患、血栓塞栓症、継続的な血液凝固モニタリングを必要とする慢性疾患の罹患率の上昇です。深部静脈血栓症(DVT)、心房細動、肺塞栓症などの疾患が流行するにつれ、信頼性が高く効率的な凝固分析装置に対する需要が急増しています。これらの疾患では、患者に抗凝固療法を行う必要がある場合が多く、治療効果の確認と副作用の予防のために頻繁なモニタリングが必要となるため、検査室ベースの凝固検査とポイントオブケア凝固検査の両方の需要が高まっています。個別化医療の増加も市場の成長に寄与しています。特に腫瘍学や心血管治療における個別化治療計画の増加に伴い、血液凝固を正確かつ頻繁にモニタリングする必要性が不可欠となっています。遺伝子治療や標的生物製剤などの個別化治療には、血液凝固に関連する特有のリスクが伴うことが多く、綿密かつ継続的な観察が必要となります。さらに、世界の高齢化の進展も大きな要因です。高齢者は血液凝固障害にかかりやすく、脳卒中、糖尿病、心臓病などの疾患を管理するために定期的な凝固検査が必要になる可能性が高いです。このような人口動態の変化が、高度な止血分析装置に対する安定した需要を牽引しています。市場成長のもう一つの促進要因は、新興市場におけるヘルスケア・インフラの拡大であり、政府やヘルスケア・プロバイダーは増大する患者の需要に対応するために最新の診断ツールに投資しています。最後に、自動化、AI、リアルタイムデータ共有の統合などの技術革新が、凝固分析装置をより効率的で正確、かつ使いやすいものにしています。これらの進歩は、検査室やヘルスケアプロバイダーが迅速かつ正確な凝固検査に対する需要の高まりに対応するのに役立っており、市場のさらなる成長を促進しています。これらの要因が相まって、現代ヘルスケアにおける凝固分析装置の重要性が拡大し、血液凝固障害の診断と管理におけるその関連性が継続することを裏付けています。

調査対象企業の例(全41件)

  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics(Schweiz)AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11117

Global Coagulation / Hemostasis Analyzers Market to Reach US$5.0 Billion by 2030

The global market for Coagulation / Hemostasis Analyzers estimated at US$4.1 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Point-of-Care Testing Analyzers segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 5.3% CAGR

The Coagulation / Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Coagulation / Hemostasis Analyzers Market - Key Trends and Drivers Summarized

Why Are Coagulation/Hemostasis Analyzers So Crucial in Healthcare?

Coagulation, or hemostasis, analyzers are vital tools in modern healthcare. These analyzers are used to assess the body’s blood clotting function, which is critical for diagnosing, treating, and managing conditions related to blood coagulation. Blood clotting disorders can lead to either excessive bleeding or thrombosis (excessive clotting), both of which are dangerous and potentially life-threatening. Coagulation analyzers perform a range of tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen levels, and D-dimer, to help healthcare providers determine how well a patient’s blood clots. These tests are essential for managing patients on anticoagulant therapies, evaluating bleeding disorders like hemophilia, and preparing patients for surgery. In emergency situations, such as trauma or stroke, rapid coagulation testing can guide immediate treatment decisions, saving lives. Given the critical nature of blood clotting in overall health, coagulation analyzers are central to diagnostics in cardiology, oncology, and surgical fields, as well as general clinical practice.

What Makes Coagulation/Hemostasis Analyzers So Advanced?

Coagulation and hemostasis analyzers are sophisticated instruments that rely on cutting-edge technologies to deliver fast, accurate, and reliable results. These devices use a variety of methods to measure the clotting process, including optical, mechanical, and electrochemical techniques. For instance, optical analyzers detect changes in the turbidity (cloudiness) of a sample as the blood begins to clot, providing precise and real-time data. Mechanical systems monitor the movement or viscosity changes in blood samples, while electrochemical systems measure changes in electrical conductivity as a clot forms. The integration of these technologies ensures that coagulation tests can be completed quickly, a necessity in critical care situations where rapid diagnosis is paramount. Modern coagulation analyzers also feature automation capabilities, allowing them to process multiple samples simultaneously, thereby increasing laboratory efficiency. They can perform a range of tests on small volumes of blood, making them ideal for use in high-throughput clinical laboratories, as well as in point-of-care settings. These analyzers are equipped with sophisticated algorithms and data analysis tools, which enhance accuracy by eliminating human error and providing standardized results. Additionally, they are often linked to laboratory information systems (LIS), enabling seamless data sharing across healthcare teams. This integration of technology makes coagulation analyzers not only faster and more reliable but also more scalable, ensuring that they can meet the growing demands of hospitals, clinics, and research institutions alike.

How Are Coagulation/Hemostasis Analyzers Evolving in Modern Medicine?

Coagulation and hemostasis analyzers are evolving rapidly in response to the changing landscape of healthcare, driven by new demands in personalized medicine, outpatient care, and technological advancements. One of the major trends is the miniaturization and portability of coagulation analyzers, which enables point-of-care testing (POCT). This shift allows healthcare providers to deliver real-time coagulation results directly at the patient’s bedside, in emergency rooms, or even in home healthcare settings. Portable coagulation analyzers are particularly beneficial for patients on long-term anticoagulant therapies, such as warfarin or direct oral anticoagulants (DOACs), who require frequent monitoring to avoid complications like excessive bleeding or clot formation. The ability to test and adjust treatment on-site improves patient outcomes and reduces the need for hospital visits, a critical consideration in modern healthcare. Moreover, the integration of digital technologies and artificial intelligence (AI) is enhancing the capabilities of coagulation analyzers. AI and machine learning algorithms are increasingly being used to analyze coagulation test results, providing deeper insights into patient health and enabling more accurate predictions of clotting disorders. These systems can flag abnormal results and even suggest potential diagnoses or treatment adjustments based on historical data, helping clinicians make more informed decisions. Additionally, many modern analyzers are now equipped with cloud connectivity, allowing for remote monitoring and real-time data sharing between healthcare providers and laboratories. This is particularly useful for managing chronic patients and those undergoing complex treatments like chemotherapy, where coagulation monitoring is essential. Advances in reagent formulations, sensor technology, and automation are also making these analyzers more precise and efficient, reducing the likelihood of sample contamination or inaccurate readings.

What Is Driving the Growth of the Coagulation/Hemostasis Analyzers Market?

The growth in the coagulation/hemostasis analyzers market is driven by several factors directly related to advancements in medical technology, patient needs, and evolving healthcare models. One of the primary drivers is the rising incidence of cardiovascular diseases, thromboembolic disorders, and chronic conditions that require ongoing blood coagulation monitoring. As conditions like deep vein thrombosis (DVT), atrial fibrillation, and pulmonary embolism become more prevalent, the demand for reliable and efficient coagulation analyzers has surged. These conditions often require patients to be placed on anticoagulant therapies, necessitating frequent monitoring to ensure therapeutic efficacy and prevent adverse effects, which in turn increases the demand for both laboratory-based and point-of-care coagulation testing. The increasing use of personalized medicine is also contributing to the market’s growth. With the rise of individualized treatment plans, particularly in oncology and cardiovascular care, the need for precise and frequent monitoring of blood coagulation has become essential. Personalized therapies, such as gene therapies or targeted biologics, often come with specific risks related to blood clotting, requiring close and continuous observation. Additionally, the growing aging population globally is another significant factor. Older adults are more susceptible to clotting disorders and are more likely to require regular coagulation testing to manage conditions such as stroke, diabetes, and heart disease. This demographic shift is driving steady demand for advanced hemostasis analyzers. Another driver of market growth is the expansion of healthcare infrastructure in emerging markets, where governments and healthcare providers are investing in modern diagnostic tools to meet growing patient demand. Finally, technological innovations, such as the integration of automation, AI, and real-time data sharing, are making coagulation analyzers more efficient, accurate, and user-friendly. These advancements are helping laboratories and healthcare providers meet the increasing demand for rapid and precise coagulation testing, driving further growth in the market. Together, these factors underscore the expanding importance of coagulation analyzers in modern healthcare, ensuring their continued relevance in the diagnosis and management of blood clotting disorders.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Coagulation / Hemostasis Analyzers - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular and Hematological Disorders Spurs Demand for Coagulation/ Hemostasis Analyzers
    • Aging Global Population Drives Adoption of Hemostasis Analyzers for Chronic Disease Management
    • Shift Towards Personalized Medicine Expands the Market for Advanced Coagulation/Hemostasis Analyzers
    • Utilization of Point-of-Care Coagulation Testing Drives Demand for Portable Hemostasis Analyzers
    • Here's How Direct Oral Anticoagulants (DOACs) Generate the Need for Specialized Hemostasis Analyzers
    • Increased Demand for Faster and More Reliable Diagnostic Results Drives Adoption of Automated Hemostasis Analyzers
    • Improving Healthcare Infrastructure in Developing Regions Expands the Addressable Market for Hemostasis Analyzers
    • Increasing Awareness of Bleeding Disorders Drives Early Diagnostic Adoption and Growth in Hemostasis Analyzer Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coagulation / Hemostasis Analyzers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Laboratory Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Laboratory Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Clinical Laboratory Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Point-of-Care Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Point-of-Care Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Point-of-Care Testing Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Optical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Optical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Optical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Electrochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Electrochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Electrochemical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • INDIA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • AFRICA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION